GO
Loading...

Cramer: JNJ Prostate Cancer Drug Better Than Dendreon's

Thursday, 8 Mar 2012 | 9:21 AM ET

CNBC's Jim Cramer explains why Johnson & Johnson's prostate cancer drug is better and cheaper than Dendreon's drug.